Tirzepatide helps obese adults lose over 15% of body weight in 52 weeks—and retain much of it even six months after stopping ...

Detailed price information for Lexaria Bioscience Corp (LEXX-Q) from The Globe and Mail including charting and trades.

Obesity has become a global epidemic, contributing to a host of chronic health conditions such as type 2 diabetes, ...

Metabolic hypogonadism, a condition marked by low testosterone levels and frequently seen in obese individuals, contributes ...

Researchers analyzed nearly 60,000 public Facebook posts to identify real-world adverse events linked to GLP-1 receptor ...

Patients regain weight after stopping weight loss drugs, long-term success may depend on lifestyle and drug choice.

Patients put on weight loss drugs like Ozempic and Wegovy may start regaining weight within weeks of discontinuing them, a ...

In a recent study published in Life Metabolism, researchers at Fudan University report that even after stopping the anti-obesity drug tirzepatide, ...

Ozempic (semaglutide) and other GLP-1 medications have helped many people lose weight and manage chronic conditions like type ...

The analysis found that while the amount of weight regain varies by drug, there is a consistent pattern of rapid weight ...

The analysis revealed a consistent trend: patients began regaining weight around eight weeks after stopping the medication, ...